Rockwell Medical, Inc.
RMTI
Price:
$0.6248
Market Cap:
$24.66M
Rockwell Medical, Inc., together with its associated companies, operates as a biopharmaceutical firm specializing in treatments for chronic and end-stage kidney disease. The company provides a range of therapies and products aimed at addressing iron deficiency and supporting hemodialysis procedures, serving markets both within the United States and internationally. A key offering includes its Triferic line (Triferic Dialysate and Triferic AVNU), an innovative iron replacement therapy. This therapy is designed to replenish iron and maintain healthy hemoglobin levels in dialysis patients, notably without increasing existing iron stores. Beyond iron management, Rockwell Medical manufactures, se...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1998-01-27
Stock Exchange
NASDAQ
Ticker
RMTI
PE Ratio
[-4.17]
ROE
[-15.41%]
Current Ratio
[3.74]
Dividend Yield
[0%]
Enterprise Value
[29.44M]
Dividend History
The ROE as of June 2026 (TTM) for Rockwell Medical, Inc. (RMTI) is -15.41%
According to Rockwell Medical, Inc.’s latest financial reports and current stock price. The company's current ROE is -15.41%. This represents a change of 294.74% compared to the average of -3.90% of the last 4 quarters.
Rockwell Medical, Inc. (RMTI) Historical ROE (quarterly & annually)
How has RMTI ROE performed in the past?
The mean historical ROE of Rockwell Medical, Inc. over the last ten years is -196.91%. The current -15.41% ROE has changed -92.17% with respect to the historical average. Over the past ten years (40 quarters), RMTI's ROE was at its highest in in the March 2022 quarter at 148.99%. The ROE was at its lowest in in the December 2021 quarter at -352.70%.
Average
-196.91%
Median
-84.58%
Minimum
-1288.92%
Maximum
-1.47%
Rockwell Medical, Inc. (RMTI) ROE by Quarter and Year
Discovering the peaks and valleys of Rockwell Medical, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.33%
Maximum Annual ROE = -1.47%
Minimum Annual Increase = -96.28%
Minimum Annual ROE = -1288.92%
| Year | ROE | Change |
|---|---|---|
| 2025 | -14.37% | 875.51% |
| 2024 | -1.47% | -96.28% |
| 2023 | -39.64% | -70.07% |
| 2022 | -132.42% | -89.73% |
| 2021 | -1288.92% | 1.33% |
| 2020 | -90.40% | -46.17% |
| 2019 | -167.95% | 42.60% |
| 2018 | -117.78% | 49.55% |
| 2017 | -78.76% | 110.61% |
| 2016 | -37.39% | 61.61% |
Rockwell Medical, Inc. (RMTI) Average ROE
How has RMTI ROE performed in the past?
The current ROE of Rockwell Medical, Inc. (RMTI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-18.49%
5-year avg
-295.36%
10-year avg
-196.91%
Rockwell Medical, Inc. (RMTI) ROE vs. Peers
How is RMTI’s ROE compared to its peers?
Rockwell Medical, Inc.’s ROE is greater than Cumberland Pharmaceuticals Inc. (-28.75%), greater than Quantum BioPharma Ltd. (-621.76%), greater than Apimeds Pharmaceuticals US, Inc (-54.62%), less than Liminatus Pharma, Inc. Class A Common Stock (215.73%), greater than Alterity Therapeutics Limited (-30.19%), greater than Star Equity Holdings, Inc. (-13.56%), greater than Talphera, Inc. (-92.98%), greater than NeuroOne Medical Technologies Corporation (-98.33%), greater than Evaxion Biotech A/S (-77.79%), greater than Mural Oncology plc (-131.47%),
| Company | ROE | Market cap |
|---|---|---|
| -28.75% | $83.91M | |
| -621.76% | $17.19M | |
| -54.62% | $1.67M | |
| 215.73% | $3.27M | |
| -30.19% | $38.16M | |
| -13.56% | $40.80M | |
| -92.98% | $17.92M | |
| -98.33% | $27.93M | |
| -77.79% | $22.99M | |
| -131.47% | $35.38M |
Build a custom stock screener for Rockwell Medical, Inc. (RMTI) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rockwell Medical, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Rockwell Medical, Inc. (RMTI) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Rockwell Medical, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Rockwell Medical, Inc.'s ROE?
How is the ROE calculated for Rockwell Medical, Inc. (RMTI)?
What is the highest ROE for Rockwell Medical, Inc. (RMTI)?
What is the 3-year average ROE for Rockwell Medical, Inc. (RMTI)?
What is the 5-year average ROE for Rockwell Medical, Inc. (RMTI)?
How does the current ROE for Rockwell Medical, Inc. (RMTI) compare to its historical average?